Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sarepta’s Elevidys Limited To Ambulatory DMD Patients
Study In Non-Ambulatory Patients Planned
Nov 14 2025
•
By
Mandy Jackson
Elevidys is contraindicated in patients with DMD exon 8 and/or 9 deletions
(Shutterstock)
More from Scrip
More from Rare Diseases